WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy
WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy have?
WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy has 50 citations in the OpenAlex counts ScholarIQ stores.
When was WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy published?
WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy has 2017 year in the ScholarIQ index.
What is the open-access status of WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy?
WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy has closed oa status in the ScholarIQ index.
What is the DOI of WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy?
The DOI for WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy is on the source record.
What is the PMID of WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy?
The PMID for WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy is on the source record.
What is the OpenAlex record for WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy?
The OpenAlex for WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy is on the source record.